| The CRAPome: a contaminant repository for affinity purification–mass spectrometry data D Mellacheruvu, Z Wright, AL Couzens, JP Lambert, NA St-Denis, T Li, ... Nature methods 10 (8), 730-736, 2013 | 1837 | 2013 |
| An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome T Bürckstümmer, C Baumann, S Blüml, E Dixit, G Dürnberger, H Jahn, ... Nature immunology 10 (3), 266-272, 2009 | 1282 | 2009 |
| Gene essentiality and synthetic lethality in haploid human cells VA Blomen, P Májek, LT Jae, JW Bigenzahn, J Nieuwenhuis, J Staring, ... Science 350 (6264), 1092-1096, 2015 | 931 | 2015 |
| Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets U Rix, O Hantschel, G Dürnberger, LL Remsing Rix, M Planyavsky, ... Blood, The Journal of the American Society of Hematology 110 (12), 4055-4063, 2007 | 791 | 2007 |
| IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA A Pichlmair, C Lassnig, CA Eberle, MW Górna, CL Baumann, TR Burkard, ... Nature immunology 12 (7), 624-630, 2011 | 610 | 2011 |
| Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ... Nature 508 (7495), 222-227, 2014 | 457 | 2014 |
| Artemisinins target GABAA receptor signaling and impair α cell identity J Li, T Casteels, T Frogne, C Ingvorsen, C Honore, M Courtney, ... Cell 168 (1), 86-100. e15, 2017 | 414 | 2017 |
| OLAV: Towards high‐throughput tandem mass spectrometry data identification J Colinge, A Masselot, M Giron, T Dessingy, J Magnin PROTEOMICS: International Edition 3 (8), 1454-1463, 2003 | 413 | 2003 |
| Cell-cycle regulation accounts for variability in Ki-67 expression levels M Sobecki, K Mrouj, J Colinge, F Gerbe, P Jay, L Krasinska, V Dulic, ... Cancer research 77 (10), 2722-2734, 2017 | 386 | 2017 |
| The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib O Hantschel, U Rix, U Schmidt, T Bürckstümmer, M Kneidinger, G Schütze, ... Proceedings of the National Academy of Sciences 104 (33), 13283-13288, 2007 | 354 | 2007 |
| SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics S Cabello-Aguilar, M Alame, F Kon-Sun-Tack, C Fau, M Lacroix, ... Nucleic acids research 48 (10), e55-e55, 2020 | 345 | 2020 |
| Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells LL Remsing Rix, U Rix, J Colinge, O Hantschel, KL Bennett, T Stranzl, ... Leukemia 23 (3), 477-485, 2009 | 332 | 2009 |
| A chemical and phosphoproteomic characterization of dasatinib action in lung cancer J Li, U Rix, B Fang, Y Bai, A Edwards, J Colinge, KL Bennett, J Gao, ... Nature chemical biology 6 (4), 291-299, 2010 | 322 | 2010 |
| Viral immune modulators perturb the human molecular network by common and unique strategies A Pichlmair, K Kandasamy, G Alvisi, O Mulhern, R Sacco, M Habjan, ... Nature 487 (7408), 486-490, 2012 | 289 | 2012 |
| CD14 is a coreceptor of Toll-like receptors 7 and 9 CL Baumann, IM Aspalter, O Sharif, A Pichlmair, S Blüml, F Grebien, ... Journal of Experimental Medicine 207 (12), 2689-2701, 2010 | 283 | 2010 |
| Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS M Varjosalo, R Sacco, A Stukalov, A Van Drogen, M Planyavsky, S Hauri, ... Nature methods 10 (4), 307-314, 2013 | 234 | 2013 |
| Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling KVM Huber, KM Olek, AC Müller, CSH Tan, KL Bennett, J Colinge, ... Nature methods 12 (11), 1055-1057, 2015 | 229 | 2015 |
| Charting the molecular network of the drug target Bcr-Abl M Brehme, O Hantschel, J Colinge, I Kaupe, M Planyavsky, T Köcher, ... Proceedings of the National Academy of Sciences 106 (18), 7414-7419, 2009 | 222 | 2009 |
| A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer MK Muellner, IZ Uras, BV Gapp, C Kerzendorfer, M Smida, ... Nature chemical biology 7 (11), 787-793, 2011 | 201 | 2011 |
| A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis A Fauster, M Rebsamen, KVM Huber, JW Bigenzahn, A Stukalov, ... Cell death & disease 6 (5), e1767-e1767, 2015 | 200 | 2015 |
Giulio Superti-FurgaScientific Director, CeMM Research Center for Molecular Medicine of the Austrian Academy ofVerified email at cemm.oeaw.ac.at